Enable Biosciences Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Enable Biosciences's estimated annual revenue is currently $1.9M per year.(i)
  • Enable Biosciences's estimated revenue per employee is $143,077

Employee Data

  • Enable Biosciences has 13 Employees.(i)
  • Enable Biosciences grew their employee count by 18% last year.

Enable Biosciences's People

NameTitleEmail/Phone
1
CEO / CFO / CMOReveal Email/Phone
2
Co-founder and CSOReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Co-Founder and Chief Operating OfficerReveal Email/Phone
5
Laboratory DirectorReveal Email/Phone
6
Senior DirectorReveal Email/Phone
7
Co-Founder and Chief Technology OfficerReveal Email/Phone
8
Director, Laboratory Operations and AutomationReveal Email/Phone
9
Client Relations ManagerReveal Email/Phone
10
Laboratory AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M50%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M4-50%N/AN/A
#6
$0.7M80%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1731%N/AN/A
Add Company

What Is Enable Biosciences?

Enable Biosciences is a South San Francisco-based diagnostics company. We develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$1.9M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Enable Biosciences News

2022-04-17 - Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics

Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of ... which will enable us to manufacture these therapies internally and...

2022-04-17 - Labcorp Enhances Cell and Gene Therapy Development ...

“The exciting projects we're undertaking with Labcorp allow our shared clients to harness the institutional ... About Xcell Biosciences

2022-04-06 - Curate Biosciences and City of Hope Evaluate Innovative Cell ...

Curate Biosciences' cell separation platform has the potential to enable up to a 50% reduction in the total cost of autologous cell therapy...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M13-78%$187.1M
#2
$1.8M13-7%N/A
#3
$0.5M13225%N/A
#4
$1.7M13-13%N/A
#5
$3.8M150%N/A